k 2021

Covid-19 Disease as a Challenge for Patent Law and Patent Strategies

KOUKAL, Pavel

Základní údaje

Originální název

Covid-19 Disease as a Challenge for Patent Law and Patent Strategies

Autoři

Vydání

Comparative Law in Times of Emergencies, 2021

Další údaje

Jazyk

angličtina

Typ výsledku

Prezentace na konferencích

Obor

50501 Law

Stát vydavatele

Itálie

Utajení

není předmětem státního či obchodního tajemství

Organizační jednotka

Právnická fakulta

Klíčová slova anglicky

patent law; covid-19; compulsory licensing; negatorial claims; patent strategy
Změněno: 22. 2. 2022 09:42, Mgr. Petra Georgala

Anotace

V originále

: COVID-19 decease has affected all areas of our society. Fighting the disease is already based on a wide variety of technical achievements like pharmaceutical ingredients and therapeutic technology. In particular, vaccines and other technological innovations are worldwide utilized and patent protected using considerable public and private research funds. The COVID-19 pandemic has had a significant impact on patent strategies for the development of new drugs, diagnostic methods or vaccines. In his presentation, the author focused on the impact of the pandemic on the possibility of asserting negator claims and also on the issue of compulsory licensing. The author argued that the debate on the waiver of patent rights that has arisen in several countries and also in the WTO does not pay the attention on the distinction between negatory claims and monetary compensation. Monetary compensation is also an essential condition for the granting of compulsory licences.